annual FCF:
-$184.46M-$27.73M(-17.70%)Summary
- As of today (July 1, 2025), XENE annual free cash flow is -$184.46 million, with the most recent change of -$27.73 million (-17.70%) on December 31, 2024.
- During the last 3 years, XENE annual FCF has fallen by -$112.91 million (-157.80%).
- XENE annual FCF is now -509.49% below its all-time high of $45.05 million, reached on December 31, 2012.
Performance
XENE Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$61.70M-$6.53M(-11.83%)Summary
- As of today (July 1, 2025), XENE quarterly free cash flow is -$61.70 million, with the most recent change of -$6.53 million (-11.83%) on March 31, 2025.
- Over the past year, XENE quarterly FCF has dropped by -$15.32 million (-33.04%).
- XENE quarterly FCF is now -421.46% below its all-time high of $19.19 million, reached on December 31, 2019.
Performance
XENE quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$199.78M-$15.32M(-8.31%)Summary
- As of today (July 1, 2025), XENE TTM free cash flow is -$199.78 million, with the most recent change of -$15.32 million (-8.31%) on March 31, 2025.
- Over the past year, XENE TTM FCF has dropped by -$33.30 million (-20.00%).
- XENE TTM FCF is now -8208.12% below its all-time high of $2.46 million, reached on September 30, 2014.
Performance
XENE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
XENE Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.7% | -33.0% | -20.0% |
| 3 y3 years | -157.8% | -231.0% | -189.2% |
| 5 y5 years | -2998.2% | -349.9% | -1462.9% |
XENE Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -157.8% | at low | -254.3% | at low | -175.5% | at low |
| 5 y | 5-year | -2998.2% | at low | -452.9% | at low | -1462.9% | at low |
| alltime | all time | -509.5% | at low | -421.5% | at low | -8208.1% | at low |
XENE Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$61.70M(+11.8%) | -$199.78M(+8.3%) |
| Dec 2024 | -$184.46M(+17.7%) | -$55.17M(+6.6%) | -$184.46M(+11.9%) |
| Sep 2024 | - | -$51.74M(+65.9%) | -$164.78M(+1.5%) |
| Jun 2024 | - | -$31.18M(-32.8%) | -$162.32M(-2.5%) |
| Mar 2024 | - | -$46.38M(+30.7%) | -$166.49M(+6.2%) |
| Dec 2023 | -$156.73M(+50.8%) | -$35.48M(-28.0%) | -$156.73M(-1.0%) |
| Sep 2023 | - | -$49.28M(+39.4%) | -$158.33M(+13.2%) |
| Jun 2023 | - | -$35.35M(-3.4%) | -$139.84M(+14.7%) |
| Mar 2023 | - | -$36.62M(-1.3%) | -$121.90M(+17.3%) |
| Dec 2022 | -$103.92M(+45.2%) | -$37.08M(+20.4%) | -$103.92M(+18.0%) |
| Sep 2022 | - | -$30.79M(+76.8%) | -$88.06M(+21.5%) |
| Jun 2022 | - | -$17.41M(-6.6%) | -$72.51M(+5.0%) |
| Mar 2022 | - | -$18.64M(-12.2%) | -$69.08M(-3.5%) |
| Dec 2021 | -$71.55M(+41.0%) | -$21.22M(+39.4%) | -$71.55M(+11.3%) |
| Sep 2021 | - | -$15.23M(+8.9%) | -$64.27M(+5.4%) |
| Jun 2021 | - | -$13.99M(-33.8%) | -$60.99M(+4.9%) |
| Mar 2021 | - | -$21.11M(+51.4%) | -$58.16M(+14.6%) |
| Dec 2020 | -$50.76M(+752.6%) | -$13.94M(+16.7%) | -$50.76M(+188.0%) |
| Sep 2020 | - | -$11.95M(+7.1%) | -$17.63M(+37.9%) |
| Jun 2020 | - | -$11.16M(-18.6%) | -$12.78M(+20.2%) |
| Mar 2020 | - | -$13.71M(-171.5%) | -$10.64M(+78.7%) |
| Dec 2019 | -$5.95M | $19.19M(-370.2%) | -$5.95M(-81.7%) |
| Sep 2019 | - | -$7.10M(-21.2%) | -$32.56M(-16.9%) |
| Jun 2019 | - | -$9.01M(-0.2%) | -$39.20M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$9.03M(+21.8%) | -$35.86M(+1.8%) |
| Dec 2018 | -$35.23M(+21.3%) | -$7.41M(-46.1%) | -$35.23M(+1.5%) |
| Sep 2018 | - | -$13.74M(+142.2%) | -$34.72M(+17.2%) |
| Jun 2018 | - | -$5.67M(-32.4%) | -$29.62M(-4.0%) |
| Mar 2018 | - | -$8.40M(+21.7%) | -$30.84M(+6.2%) |
| Dec 2017 | -$29.04M(+46.3%) | -$6.90M(-20.1%) | -$29.04M(+8.2%) |
| Sep 2017 | - | -$8.64M(+25.2%) | -$26.84M(+17.9%) |
| Jun 2017 | - | -$6.90M(+4.6%) | -$22.77M(+6.3%) |
| Mar 2017 | - | -$6.60M(+40.4%) | -$21.42M(+7.9%) |
| Dec 2016 | -$19.85M(+6.4%) | -$4.70M(+2.8%) | -$19.85M(-3.4%) |
| Sep 2016 | - | -$4.57M(-17.7%) | -$20.54M(-2.5%) |
| Jun 2016 | - | -$5.55M(+10.4%) | -$21.07M(+16.7%) |
| Mar 2016 | - | -$5.03M(-6.7%) | -$18.05M(-3.2%) |
| Dec 2015 | -$18.65M(+1377.0%) | -$5.39M(+5.6%) | -$18.65M(+9.8%) |
| Sep 2015 | - | -$5.10M(+101.7%) | -$16.99M(+189.9%) |
| Jun 2015 | - | -$2.53M(-55.1%) | -$5.86M(+5.2%) |
| Mar 2015 | - | -$5.63M(+51.1%) | -$5.57M(+341.2%) |
| Dec 2014 | -$1.26M(-63.7%) | -$3.73M(-161.8%) | -$1.26M(-151.3%) |
| Sep 2014 | - | $6.03M(-368.9%) | $2.46M(-169.1%) |
| Jun 2014 | - | -$2.24M(+69.6%) | -$3.56M(+169.6%) |
| Mar 2014 | - | -$1.32M | -$1.32M |
| Dec 2013 | -$3.48M(-107.7%) | - | - |
| Dec 2012 | $45.05M(-422.2%) | - | - |
| Dec 2011 | -$13.98M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual FCF year-on-year change?
- What is Xenon Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly FCF year-on-year change?
- What is Xenon Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM FCF year-on-year change?
What is Xenon Pharmaceuticals annual free cash flow?
The current annual FCF of XENE is -$184.46M
What is the all time high annual FCF for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual free cash flow is $45.05M
What is Xenon Pharmaceuticals annual FCF year-on-year change?
Over the past year, XENE annual free cash flow has changed by -$27.73M (-17.70%)
What is Xenon Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of XENE is -$61.70M
What is the all time high quarterly FCF for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly free cash flow is $19.19M
What is Xenon Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, XENE quarterly free cash flow has changed by -$15.32M (-33.04%)
What is Xenon Pharmaceuticals TTM free cash flow?
The current TTM FCF of XENE is -$199.78M
What is the all time high TTM FCF for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM free cash flow is $2.46M
What is Xenon Pharmaceuticals TTM FCF year-on-year change?
Over the past year, XENE TTM free cash flow has changed by -$33.30M (-20.00%)